Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
novel transcript, antisense to RIMBP2 (ENSG00000296703)
- Target
- ENSG00000296703
- Molecular classification
- Long non-coding RNA, Antisense RNA, Non-coding transcript
01
Overview
The "novel transcript, antisense to RIMBP2" is a long non-coding RNA (lncRNA) transcribed from the DNA strand opposite to that of the RIMS binding protein 2 (RIMBP2) gene. Antisense RNAs are commonly produced across mammalian genomes and often act to regulate expression of their sense (protein-coding) gene partners through mechanisms such as transcriptional interference, chromatin modifications, or RNA duplex formation that can regulate mRNA stability or processing[3][6]. The precise function of this particular transcript remains unknown, and it is not currently considered a druggable or classical therapeutic target. In general, antisense transcripts across human genes can shape gene expression and cellular physiology through epigenetic or post-transcriptional mechanisms, but the vast majority, including ENSG00000296703, have not been functionally characterized in detail[3][6].
- Other names
- Antisense transcript to RIMBP2ENSG00000296703 (Ensembl gene ID)Non-coding RNA antisense to RIMBP2
02
Mechanism of action
Not applicable; no drugs reported to target this transcript
03
Biological functions
Possible transcriptional regulation of RIMBP2 (by analogy to other antisense RNAs, general references for antisense RNA function[3][6])Possible chromatin modification or epigenetic regulation[3]Other (unknown — not experimentally annotated for this specific transcript)
04
Disease associations
Other (unknown — there are no established disease associations for this antisense transcript; RIMBP2 itself has some cancer association, but not the antisense transcript[1])Antisense RNAs in general have been implicated in diverse processes including cancer regulation, but this is not shown for this specific one[3][6]
Beyond the preview
Go deeper on novel transcript, antisense to RIMBP2 (ENSG00000296703).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on novel transcript, antisense to RIMBP2 (ENSG00000296703).